Court Laurence E, Tishler Roy B
Department of Radiation Oncology, Dana-Farber and Brigham and Women's Cancer Center, Boston, MA 02115, USA.
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):607-13. doi: 10.1016/j.ijrobp.2007.03.004.
To investigate experimentally the impact of different head-and-neck intensity-modulated radiation therapy (IMRT) planning techniques on doses to the skin and shallow targets.
A semicylindrical phantom was constructed with micro-MOSFET dosimeters (Thomson-Nielson, Ottawa, Ontario, Canada) at 0-, 3-, 6-, 9-, and 12-mm depths. The planning target volume (PTV) was pulled back 0, 3, or 5 mm from the body contour. The IMRT plans were created to maximize PTV coverage, with one of the following strategies: (a) aim for a maximum 110% hotspot, with 115% allowed; (b) aims for a maximum 105% hotspot; (c) aims for a maximum 105% hotspot and 50% of skin to get a maximum 70% of the prescribed dose; and (d) aim for 99% of the PTV volume to receive 90-93% of prescribed dose, with a maximum 105% hotspot, and with the dose to the skin structure minimized. Doses delivered using a linear accelerator were measured. Setup uncertainty was simulated by intentionally shifting the phantom in a range of +/-8 mm, and calculating the delivered dose for a range of systematic and random uncertainties.
From lowest to highest skin dose, the planning strategies were in the order of c, d, b, and a, but c showed a tendency to underdose tissues at depth. Delivered doses varied by 10-20%, depending on planning strategy. For typical setup uncertainties, cumulative dose reduction to a point 6 mm deep was <4%.
It is useful to use skin as a sensitive structure, but a minimum dose constraint must be used for the PTV if unwanted reductions in dose to nodes near the body surface are to be avoided. Setup uncertainties are unlikely to give excessive reductions in cumulative dose.
通过实验研究不同的头颈部调强放射治疗(IMRT)计划技术对皮肤和浅表靶区剂量的影响。
构建一个半圆柱形模体,在0、3、6、9和12毫米深度处放置微型金属氧化物半导体场效应晶体管剂量仪(Thomson-Nielson,渥太华,安大略省,加拿大)。计划靶区(PTV)从体轮廓向后拉0、3或5毫米。创建IMRT计划以最大化PTV覆盖,采用以下策略之一:(a)目标是最大热点剂量为110%,允许115%;(b)目标是最大热点剂量为105%;(c)目标是最大热点剂量为105%且50%的皮肤接受最大70%的处方剂量;(d)目标是99%的PTV体积接受90 - 93%的处方剂量,最大热点剂量为105%,并使皮肤结构的剂量最小化。测量使用直线加速器输送的剂量。通过有意将模体在±8毫米范围内移动来模拟设置不确定性,并计算一系列系统和随机不确定性下的输送剂量。
从最低到最高的皮肤剂量,计划策略顺序为c、d、b和a,但c显示出对深部组织剂量不足的趋势。输送剂量根据计划策略变化10 - 20%。对于典型的设置不确定性,深度为6毫米处的累积剂量减少<4%。
将皮肤作为敏感结构是有用的,但如果要避免体表附近淋巴结剂量不必要的减少,则必须对PTV使用最小剂量约束。设置不确定性不太可能导致累积剂量过度减少。